InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Parlati Francesco, Directeur. Director active across 1 companies, notably Calithera Biosciences, Inc.. Cumulatively, 8 filings have been published. The latest transaction was filed on 21 January 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is free.
Declarations8 total
€2,0834,794 shares@ €0.434485.49% mcap16.5% of flow
Common Stock
SEC:0000899243-22-003139·
€2,0834,794 shares@ €0.434485.49% mcap8.2% of flow
Common Stock
SEC:0000899243-22-003139:0·
€10,56318,077 shares@ €0.584383.5% of flow
Common Stock
SEC:0000899243-22-001301·
€10,56318,077 shares@ €0.584341.8% of flow
Common Stock
SEC:0000899243-22-001301:0·
030,000 shares0
Common Stock
SEC:0000899243-21-043680·
030,000 shares0
Common Stock
SEC:0000899243-21-043680:0·
090,000 shares0
Common Stock
SEC:0000899243-21-042062·
090,000 shares0
Common Stock
SEC:0000899243-21-042062:0·
8 of 8 declarations
About Parlati Francesco
Parlati Francesco is SR. VP of research at Calithera Biosciences, Inc., a biopharmaceutical company. He oversees research and development programs, contributing to innovation and advancement in medical treatments.
